ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TTG Tt Electronics Plc

106.50
-1.50 (-1.39%)
Last Updated: 13:26:05
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tt Electronics Plc LSE:TTG London Ordinary Share GB0008711763 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50 -1.39% 106.50 106.00 107.00 108.50 104.50 108.50 1,068,672 13:26:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Components, Nec 613.9M -6.8M -0.0383 -27.81 191.95M
Tt Electronics Plc is listed in the Electronic Components sector of the London Stock Exchange with ticker TTG. The last closing price for Tt Electronics was 108p. Over the last year, Tt Electronics shares have traded in a share price range of 71.00p to 184.00p.

Tt Electronics currently has 177,735,491 shares in issue. The market capitalisation of Tt Electronics is £191.95 million. Tt Electronics has a price to earnings ratio (PE ratio) of -27.81.

Tt Electronics Share Discussion Threads

Showing 3951 to 3974 of 4225 messages
Chat Pages: 169  168  167  166  165  164  163  162  161  160  159  158  Older
DateSubjectAuthorDiscuss
17/3/2022
12:23
Day two of interesting exchanges here with numerous significant blocks hitting the book (3x410k, 490k and a 900k so far) at 201.5p and volume up to 2.6m.

Watching closer now because these buyers are keen and trying very hard to clear the sellers, but the book is still stacked with sell orders on the offer from 203p in increments up to 206p preventing any break higher.

The book can turn quickly at TTG too so might be worth keeping an eye on to see if these big buyers can exhaust the sellers for a technical bounce.

Sometimes I have a go and it doesn't work. When it doesn't work, can always exit with a little loss but really need to see the offer getting cleared first as per the above post or the sellers could win this crucial battle.

All imo
DYOR

sphere25
16/3/2022
10:44
There are some interesting blocks going through here at 201p. In a bullish market the likelihood is that TTG breaks higher on buyers coming in to clear sellers like this. However, this market has big sellers at particular price points and then various layers of further big sellers at higher price points, so even if something bounces, it just gets sold back down.

The exchanges are notable for TTG and could lead to a technical bounce if the buying is heavy enough but it is a stalemate in a firm downtrend at the moment.

We are at 2.17m and rising at the moment with numerous blocks of 250k hitting the book. Clearly if some absolute whoppers hit, then a bounce is more probable, but someone is still sat with a big sell order at 201p at the moment that the bulls are trying to buy out.

TTG really need to clear and close above 205p for a bounce but if the sellers win out with the buyers getting exhausted, then it could lurch back down very easily. Nonetheless, interesting activity and a decent example of what is going on out there. Sometimes it is hard to see the sellers and wonder why the prices aren't bouncing back significantly higher.

All imo
DYOR

sphere25
14/3/2022
13:27
I think the zero tolerance policy out there has been a long standing niggle for all those who operate out there. Latest news not helpful but probably not much worse than what they have been dealing with
eigthwonder
14/3/2022
11:25
Anyone on this thread have a view on the latest China lockdown. I read that Shenzhen in China is locked down - is TT, Luceco, others affected adversely by this?
camdenhills
09/3/2022
19:32
I think management has radically changed the portfolio of businesses for the better.

Management's note is reassuring: "Restructuring costs charged in the period primarily relate to cost of the Group's self help programme which began in 2020 and it is expected to conclude in 2022. To date the total income statement expense of the self help programme has been £21.0 million and with the total cost estimated to be £23.4 million."

cellars
09/3/2022
08:17
A decent set of figures from the revenue and production pov. The cash flow leaves something to be desired, in part understandable on working capital grounds but how much more in reorganisation costs may be required going forward?
Acquisitions provide additional scope for fudging the 'adjustments' and I would like to see an independant critical analysis of these figures.

boadicea
08/3/2022
17:39
Results coming out tomorrow (Wednesday, 9th.)
boadicea
03/2/2022
10:56
it a boring company
my retirement fund
02/2/2022
20:36
Has everyone on this board died?There must be some comments from some of you, either on results or acquisition. Seems quite extraordinary, unless you're all hiding on another board?
bummel45
06/8/2021
08:38
Bummel, I think the issue is that TT makes extensive use of non-statutory adjustments to make the figures look better than they actually are. Every set of accounts I've seen over the last 15 years have non-statutory adjustments which mean that now I only look at the statutory figures. The statutory figures have flatlined so it is difficult to understand how management can claim them to be anything other than average.

The only glimmer I see is that orderbook is up - hopefully at some stage they will stop relying on accounting tricks and genuinely have something worth shouting about but they are not there yet.

Funnily enough, I see TT as a potential takeover target given recent sector activity and the apparent poor management. There must be an opportunity for private equity/sector leader to sort it out?

overeager
05/8/2021
19:26
It's quite extraordinary - no comments from anyone on here about today's excellent results!
Has everyone left, or is there another board that I have missed?

bummel45
24/7/2021
10:59
Any recent news on how Virolens trials are going, not seen anything since April 21.
Thanks

northener
09/7/2021
17:48
Read a few papers/studies regarding antibodies, either from recovered or vaccine, and it appears that in the elderly they do wane quite noticeably.
Ok, antibodies are not the whole picture, memory cells etc.

But what I was wondering, is if the gov want to rightly target a cohort, could the virolens machine be set up to detect antibodies?

As it seems a far chunk of kit to just look for the virus.

No point in vaccinating folk who still have good antibody levels, what with the risk of adverse reactions

games
07/6/2021
19:43
Given its history one would expect it to need substantial good news to break through the 250/260p range. Too many neddies will just be happy to see their money back unless a big juicy carrot dangles in the near future.
boadicea
02/5/2021
11:12
Interestinghttps://www.thenorthernecho.co.uk/news/19271133.chancellor-rishi-sunak-visits-hartlepool-firm-developing-ground-breaking-covid-test/
tinfoil
29/4/2021
04:53
That remains to be seen.
glavey
27/4/2021
19:49
19/04/21. XTEK Ltd's (ASX:XTE) managing director Phillipe Odouard speaks to Proactive soon after signing an agreement with KeyOptions Pty Ltd to exclusively distribute and support Virolens, which is designed to screen for SARS-CoV-2 in around 20-30 seconds, in Australia, New Zealand and the Pacific independent states. The Virolens system is a COVID-19 screening device based on microscopic holographic imaging and artificial intelligence (AI) software technology.
136,000 shares bought after close reckless fools, what do they know?

earwacks
27/4/2021
04:48
3 monkeys.
glavey
25/4/2021
22:15
Where did Glavey go??
tinnerz187
25/4/2021
06:55
Hi earwacks, yes i agree it doesn't matter what other people think. We are all just looking for earnings growth in the end. I don't follow that person on stockopedia, and don't use stockopedia in fact, but again there is always a load of noise out there. I guess that is part of where mispricing comes from.

I also agree about the press in general and specifically for the virolens product. I reckon i have learnt something by this situation about how to handle the press. The ft in particular as per my rant a few posts ago i think were disgraceful. Three separate journalists just wrote lazy, judgemental articles. Technology business development (i mean physical technology products not software) is a very very tough world, i know from experience. But if something potentially ticks all the boxes it should 100% be given a chance... whether by the press, vc investors, tech incubators or whatever. Not only because that is where innovation and economic growth come from but also because when things win they win big, and it does happen every now and then. Actually here we have exposure to an interesting new product via an established company which is great.

aringadingding
24/4/2021
08:58
At the end of the day Ari, it doesn't make any difference what people say. I was really surprised when PS on Stockopeia felt he got stung buying into the spike when Sky broke the story on Virolens in September. Really an experienced investor like him should know better. Buy on rumour sell on news. He spikes shares everyday with his stock reporting. Some of his analysis is excellent and pretty open about not understanding some sectors. They must also be aware that although they are not recommending shares obviously they have a big enough following to effect share price movement to some degree particularly with small companies when they write an enthusiastic report and similarly when they dismiss a company sometimes unjustly.
I do occasionally feel I can't let posts go unanswered, when they clearly have the wrong end of the stick or simply too lazy to research themselves just spouting media tosh. Also I find it quite disrespectful to the companies and other genuine investors.
I can't remember the inventors name of Iabra, but here is a guy already using AI in other products who had the nowse to come up with this idea, and within three months have the first prototype in partnership wih TTG tested in the field. Genuinely offering a solution in a serious crisis. What do the media do? savage them with their own ignorance stupidity. Dyson was asked by the government if he could help out with the manufacture of ventilators.He agreed to do this on a non profit basis in return that his workers should not have to pay uk tax. Media savage him. AZn no profit making vaccine. The EU want to sue for not fulfilling contract on a vaccine they have clearly stated they won't use. Probably they feel they could have profited from this by selling them on. What is a matter with all these loonies?

earwacks
24/4/2021
06:37
Very well said earwacks. It's all about the long term potential for this product in both crisis and everyday healthcare.
aringadingding
24/4/2021
06:18
The MHRA does not issue approvals for COVID-19 tests in the way it does for vaccines, having determined they are effective, but registers medical devices with a certification mark if they meet legal criteria, are safe and are made to the standard specified by the manufacturer for the stated purpose. This is not medicine its a testing device.

Histate said trials had indicated the test had 98.1% sensitivity, meaning it returns few false negatives, and 99.7% specificity, meaning few false positives.This is in fact a better result than the one back in September discredited by afore mentioned idiot journalist.

"Britain gives the go ahead for Virolens 20 second test.' Those are media headlines not the company headlines. MHRA registration totally legitimises the sale of Virolens in the UK. They seeking similar approval in other countries.
They have clearly stated that sales entirely depend on confirmation of interest turning into orders. They satisfactorily completed testing at the Brewery, an events company desperate to reopen within a safe environment in London, like thousands of other businesses and entertainment sports venues around the world. I believe they have now moved on to a London Airport to see how it could operate and help speed up the process of passengers through checks outs.

I don't know what on earth you mean when you say 'the purpose for the placing is irrelevant.' One of the most ridiculous statements I have read on any BB.It was quite clearly stated for the reason behind the placing. TTG in no way ramped the product that was entirely down to an Iabra, a statement from the boss at Heathrow, and and over eager journalism hungry for a story. To suggest they suddenly decided to buy an American company on the back of a media story about Virolens is frankly stupid beyond belief. They may have quite sensibly taken advantage of the opportunity that presented itself. Thats what a good business does. To suggest they manufactured a situation like that is quite ludicrous.
Virolens is a great British invention that has more potential than any other product on the market to rapidly detect any pathogens being carried by humans or animals after further research. TTG are another very capable British company and I have absolutely no doubt about the integrity of either of them. Finally the boss of Iabra actually apologised for the medias misinterpretation of what he actually said or meant. I don't know if you have ever been interviewed by the media , but I am well aware of media trying to put words into your mouth rather than reporting what you actually say. Its no wonder they are being very much more careful about statements to the press, which is a good thing. In fact the Iabra boss won't speak to media at all now, which is hardly surprising having been ambushed twice at airports. We are great inventors and all the media wants to do is build people up to shoot them down to sell their papers, which is why fewer and fewer people buy their lies.

If you don't like these companies thats fine, don't invest. If you are not invested then take your malicious gossip and annoy some other bb please.

earwacks
24/4/2021
04:05
For what they raised is irrelevant. That they 'covid ramped' immediately prior is relevant.

"Registration does not represent any form of accreditation, certification or approval by the UK Competent Authority(MHRA)".

I prefer the integrity of the FT to your view, sorry

glavey
Chat Pages: 169  168  167  166  165  164  163  162  161  160  159  158  Older

Your Recent History

Delayed Upgrade Clock